Mr Mason was also recently appointed to the newly created position of group president of North America at Orthofix, and will continue in that role.
Mr Mason was previously the president of Breg, the company’s sports medicine subsidiary. Oliver Burckhardt, the previous president of Blackstone, will be leaving Orthofix to pursue other opportunities.
Alan Milinazzo, CEO of Orthofix, said: “We are very focused on the performance of our spine implant and biologic business, which has not met our expectations through the first half of 2008. We believe the initiatives underway related to new product development and the enhancement of our distribution network are critical to the improved performance we expect in 2009 and beyond.
“In addition to Brad’s proven leadership skills, his extensive product development and distribution experience will strengthen our capabilities in these key areas.”